HIMS & HERS HEALTH, INC.

Lobbying for HIMS & HERS HEALTH, INC. · Telehealth services

Filing 3rd Quarter - Amendment

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Jan 23, 2026

Expenses

$330,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

California

Official filing document

Lobbyists on this filing 1

WHITNEY JONES New on this filing

Previously held: Health Policy Analyst, Sen. Rep. Pol. Comm. (2018-2022)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 5

HR 5316
Drug Shortage Compounding Patient Access Act of 2025
HR 4605
End Prescription Drug Ads Now Act
HR 238
Healthy Technology Act of 2025
S 5040
Protecting Patients from Deceptive Drug Ads Online Act
S 2068
End Prescription Drug Ads Now Act

Lobbying activity 1

Health Issues

Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.